Stock Updates

Today’s Top Gainers in the Market Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) from Healthcare

Today’s top gainers include the company Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) which is in the industry Biotechnology, gaining 1.36% today. In the last week its performance is 1.47%, and -19.13% for the past quarter. Currently, Alexion Pharmaceuticals, Inc., ALXN has a target price of 185.83, so today’s gain of 1.36% is a significant step towards its target price. The GAP today is therefore 1.24%.

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), has a market cap of 28166.26, and is based in USA. Insider ownership is at 0.60%, and institutional ownership is 98.70%.

At the current price of 125.15, it has a dividend yield of *TBA, and its target price is 185.83. This is with a profit margin of 5.40%, and total debt/equity of 0.4. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has a P/E of 174.3, as well as a forward P/E of 19.

With a current EPS of 0.72, and a forecasted EPS growth for next year at 30.33%,Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has had a EPS growth for the past five years at 5.10%. For the next five years EPS growth is projected to be 21.01%.

Performance for the year is -38.59%. Since its IPO date on 2/28/1996, the total performance to date is -34.39%.

Volume today for Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), is 1317400, while its average volume is 1881.06. Whilst the total gain today was 1.36%, it did have a day high of -20.30%.

Volatility for this week has been at 2.03%, and 2.97% for the month. The 52-week low for Alexion Pharmaceuticals, Inc., ALXN has been 13.20%, while the 52-week-high has reached -40.09%.

Looking at its return of investments, which is 1.60%, and its return on assets is 1.10%. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has an operating margin of 22.10%. With a sales growth of 16.80% quarter over quarter. Bearing in mind that Alexion Pharmaceuticals, Inc., ALXN is in the sector Healthcare, its long-term debt/equity is 0.4, and has a current ratio of 3.5 and 3 for quick ratio.

So what is the value of Alexion Pharmaceuticals, Inc.? Well its PEG is 8.3, and the P/S is 10.41, along with a P/B of 3.49. Meanwhile it has a p/cash of 27.41.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Tony Dabbs

Leave a Comment